Hepatocellular Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma Interventions: Drug: Recombinant Human Adenovirus Type 5; Drug: Lenvatinib; Drug: Tislelizumab Sponsors: First Affiliated Hospital Bengbu Medical College Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials

Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
Conditions: Liver Transplant; Hepatocellular Carcinoma Recurrent; Systemic Treatment Interventions: Drug: Systemic therapy Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials

Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation
Conditions: Hepatocellular Carcinoma Interventions: Drug: PD-1 Inhibitors Sponsors: Chen Xiaoping Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials

Find HDV and Determine Its Status in Turkey
Conditions: Chronic Hepatitis D Infection With Hepatitis B Carrier State (Diagnosis); Fibrosis, Liver; Hepatocellular Carcinoma; Cirrhosis, Liver; Transmission Vertical Interventions: Diagnostic Test: Anti Delta Sponsors: Yasar Bay ındır; SOUTHEAST NEUROLOGY AND INFECTIOUS DISEASES SOCIETY; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials

Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.
Conditions: Hepatocellular Carcinoma Interventions: Procedure: Liver resection; Procedure: Locoregional therapy Sponsors: Chen Xiaoping Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials

Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy
Conditions: Hyperthermic Intraperitoneal Chemotherapy; Hepatocellular Carcinoma; Ruptured Liver Interventions: Procedure: intraperitoneal hyperthermic perfusion chemotherapy Sponsors: Zhujiang Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials

Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension
Conditions: Hepatic Carcinoma Interventions: Procedure: transarterial chemoembolisation Sponsors: Tang-Du Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials

Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function
Conditions: Hepatic Cancer Interventions: Procedure: transarterial chemoembolisation Sponsors: Tang-Du Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials

HAIC (Hepatic Artery Infusion Chemotherapy ，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma Interventions: Drug: Donafenib ； Sintilimab； HAIC Sponsors: Wuhan Union Hospital, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials

Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.
Conditions: Advanced Hepatocellular Carcinoma Interventions: Other: No intervention Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials

Immunotherapy for Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma; Immunotherapy Interventions: Other: Immunotherapy-based Combination Therapies Sponsors: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials

A Study of MGC026 in Participants With Advanced Solid Tumors
Conditions: Advanced Solid Tumor; Advanced Cancer; Metastatic Cancer; Squamous Cell Carcinoma of Head and Neck; Non Small Cell Lung Cancer; Small-cell Lung Cancer; Bladder Cancer; Sarcoma; Endometrial Cancer; Melanoma; Castration Resistant Prostatic Cancer; Cervical Cancer; Colorectal Cancer; Gastric Cancer; Gastro-esophageal Cancer; Pancreas Cancer; Clear Cell Renal Cell Carcinoma; Hepatocellular Carcinoma; Platinum-resistant Ovarian Cancer Interventions: Biological: MGC026 Dose Escalation; Biological: MGC026 Dose for Expansion Sponsors: MacroGenics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials

A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors
Conditions: Advanced Solid Tumors; Hepatocellular Carcinoma Interventions: Drug: AST-3424 Sponsors: Ascentawits Pharmaceuticals, Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials

Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation
Conditions: Hepatocellular Carcinoma; Liver Transplant; Complications Interventions: Device: D-HOPE machine perfusion; Procedure: Liver transplantation Sponsors: Azienda Ospedaliero-Universitaria di Modena Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials

Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant
Conditions: Hepatocellular Carcinoma Recurrent; Hepatocellular Carcinoma Interventions: Drug: Non-Selective Beta-Adrenoreceptor Agonists for Systemic Use Sponsors: Asan Medical Center; Korea Health Industry Development Institute Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials